CVS Health Overview
CVS Health Target Price
Where could CVS trade next? Consensus target price: $110.
Get informed when a big investor buys or sells
+ FollowShare Price
$104.43
Average Target Price
$108.42
3.8% upside
3.8% upside19 analysts in the last 4 months
High: $123 | Low: $92
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-24 | UBS | $122 | 16.8% upside |  |
| 2026-07-14 | Truist FinancialDavid MacDonald | $118 | 13% upside | |
| 2026-07-13 | Wells Fargo | $123 | 17.8% upside | |
| 2026-07-09 | RBC Capital | $113 | 8.2% upside | |
| 2026-07-07 | Cantor Fitzgerald | $110 | 5.3% upside | |
| 2026-07-06 | HSBC | $103 |  1.4% downside | |
| 2026-06-08 | Mizuho Securities | $115 | 10.1% upside | |
| 2026-06-04 | Morgan Stanley | $111 | 6.3% upside | |
| 2026-06-01 | Truist Financial | $108 | 3.4% upside | |
| 2026-06-01 | Piper SandlerJessica Tassan | $113 | 8.2% upside | |
| 2026-05-26 | BarclaysAndrew Mok | $106 | 1.5% upside | |
| 2026-05-20 | Mizuho Securities | $110 | 5.3% upside | |
| 2026-05-14 | Morgan Stanley | $106 | 1.5% upside | |
| 2026-05-13 | Bernstein | $106 | 1.5% upside | |
| 2026-05-07 | RBC Capital | $107 | 2.5% upside | |
| 2026-05-07 | Deutsche Bank | $92 | 11.9% downside | |
| 2026-05-07 | Truist Financial | $102 | 2.3% downside | |
| 2026-05-07 | BarclaysAndrew Mok | $101 | 3.3% downside | |
| 2026-04-15 | Robert W. Baird | $94 | 10% downside | |
| 2026-03-05 | Leerink PartnersMichael Cherny | $98 | 6.2% downside | |
| 2026-01-28 | Argus Research | $90 | 13.8% downside | |
| 2026-01-06 | Bernstein | $91 | 12.9% downside | |
| 2025-12-12 | Bernstein | $87 | 16.7% downside | |
| 2025-12-10 | Mizuho SecuritiesAnn Hynes | $95 | 9% downside | |
| 2025-12-10 | Robert W. Baird | $92 | 11.9% downside | |
| 2025-12-10 | Piper SandlerJessica Tassan | $101 | 3.3% downside | |
| 2025-12-10 | Morgan Stanley | $93 | 10.9% downside | |
| 2025-12-10 | Barclays | $93 | 10.9% downside | |
| 2025-12-10 | UBSKevin Caliendo | $97 | 7.1% downside | |
| 2025-12-10 | Truist Financial | $100 | 4.2% downside | |
| 2025-12-04 | Bernstein | $86 | 17.6% downside | |
| 2025-10-30 | RBC Capital | $93 | 10.9% downside | |
| 2025-10-24 | UBS | $96 | 8.1% downside | |
| 2025-10-14 | Truist FinancialDavid MacDonald | $92 | 11.9% downside | |
| 2025-10-14 | Morgan StanleyErin Wright | $89 | 14.8% downside | |
| 2025-10-14 | Goldman Sachs | $91 | 12.9% downside | |
| 2025-10-09 | Mizuho SecuritiesAnn Hynes | $88 | 15.7% downside | |
| 2025-10-07 | Wells Fargo | $103 | 1.4% downside | |
| 2025-09-04 | BarclaysAndrew Mok | $87 | 16.7% downside | |
| 2025-08-18 | UBSKevin Caliendo | $79 | 24.4% downside | |
| 2025-08-14 | Robert W. BairdMichael Ha | $82 | 21.5% downside | |
| 2025-06-02 | BarclaysAndrew Mok | $79 | 24.4% downside | |
| 2025-02-18 | Argus Research | $77 | 26.3% downside | |
| 2024-12-03 | Deutsche BankGeorge Hill | $66 | 36.8% downside | |
| 2024-11-18 | Wells FargoStephen Baxter | $66 | 36.8% downside | |
| 2024-10-24 | Mizuho SecuritiesAnn Hynes | $66 | 36.8% downside | |
| 2024-10-21 | Truist FinancialDavid MacDonald | $76 | 27.2% downside | |
| 2024-10-21 | Piper SandlerJessica Tassan | $72 | 31.1% downside | |
| 2024-10-10 | BarclaysAndrew Mok | $82 | 21.5% downside | |
| 2024-08-08 | Deutsche BankGeorge Hill | $63 | 39.7% downside | |